申请人:Board of Regents, The University of Texas System
公开号:US20170340636A1
公开(公告)日:2017-11-30
The present invention concerns compounds and their use to treat cell proliferative disorders including tumor growth and metastasis. Compounds of the present invention act as inhibitors of TAOK2 and modulators of autophagy, thereby functioning as anti-cancer or cancer-preventative therapeutic agents.